Abstract
Molecules encoded by the Major Histocompatibility Complex (MHC) bind self or foreign peptides and display these at the cell surface for recognition by receptors on T lymphocytes (designated T cell receptors—TCR) or on natural killer (NK) cells. These ligand/receptor interactions govern T cell and NK cell development as well as activation of T memory and effector cells. Such cells participate in immunological processes that regulate immunity to various pathogens, resistance and susceptibility to cancer, and autoimmunity. The past few decades have witnessed the accumulation of a huge knowledge base of the molecular structures of MHC molecules bound to numerous peptides, of TCRs with specificity for many different peptide/MHC (pMHC) complexes, of NK cell receptors (NKR), of MHC-like viral immunoevasins, and of pMHC/TCR and pMHC/NKR complexes. This chapter reviews the structural principles that govern peptide/MHC (pMHC), pMHC/TCR, and pMHC/NKR interactions, for both MHC class I (MHC-I) and MHC class II (MHC-II) molecules. In addition, we discuss the structures of several representative MHC-like molecules. These include host molecules that have distinct biological functions, as well as virus-encoded molecules that contribute to the evasion of the immune response.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham JP, Barker DJ, Robinson J, Maccari G, Marsh SGE (2018) The IPD databases: cataloguing and understanding allele variants. Methods Mol Biol 1802:31–48
Adams EJ, Chien YH, Garcia KC (2005) Structure of a gammadelta T cell receptor in complex with the nonclassical MHC T22. Science 308:227–231
Adams EJ, Juo ZS, Venook RT, Boulanger MJ, Arase H, Lanier LL, Garcia KC (2007) Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. Proc Natl Acad Sci USA 104:10128–10133
Adams EJ, Luoma AM (2013) The adaptable major histocompatibility complex (MHC) fold: structure and function of nonclassical and MHC class I-like molecules. Annu Rev Immunol 31:529–561
Anders AK, Call MJ, Schulze MS, Fowler KD, Schubert DA, Seth NP, Sundberg EJ, Wucherpfennig KW (2011) HLA-DM captures partially empty HLA-DR molecules for catalyzed removal of peptide. Nat Immunol 12:54–61
Artyomov MN, Lis M, Devadas S, Davis MM, Chakraborty AK (2010) CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery. Proc Natl Acad Sci USA 107:16916–21
Awad W, Le Nours J, Kjer-Nielsen L, McCluskey J, Rossjohn J (2018) Mucosal-associated invariant T cell receptor recognition of small molecules presented by MR1. Immunol Cell Biol 96:588–597
Batuwangala T, Shepherd D, Gadola SD, Gibson KJ, Zaccai NR, Fersht AR, Besra GS, Cerundolo V, Jones EY (2004) The crystal structure of human CD1b with a bound bacterial glycolipid. J Immunol 172:2382–2388
Bentley GA, Boulot G, Karjalainen K, Mariuzza RA (1995) Crystal structure of the beta chain of a T cell antigen receptor. Science 267:1984–1987
Berman HM, Battistuz T, Bhat TN, Bluhm WF, Bourne PE, Burkhardt K, Feng Z, Gilliland GL, Iype L, Jain S, Fagan P, Marvin J, Padilla D, Ravichandran V, Schneider B, Thanki N, Weissig H, Westbrook JD, Zardecki C (2002) The protein data bank. Acta Crystallogr D Biol Crystallogr 58:899–907
Bernard A, Gay-Bellile V, Amiot M, Caillou B, Charbord P, Boumsell L (1984) A novel human leukocyte differentiation antigen: monoclonal antibody anti-D44 defines a 28 Kd molecule present on immature hematologic cells and a subpopulation of mature T cells. J Immunol 132:2338–2344
Bjorkman PJ, Parham P (1990) Structure, function, and diversity of class I major histocompatibility complex molecules. Annu Rev Biochem 59:253–288
Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC (1987) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506–512
Blees A, Januliene D, Hofmann T, Koller N, Schmidt C, Trowitzsch S, Moeller A, Tampe R (2017) Structure of the human MHC-I peptide-loading complex. Nature 551:525–528
Blum JS, Wearsch PA, Cresswell P (2013) Pathways of antigen processing. Annu Rev Immunol 31:443–473
Bork P, Holm L, Sander C (1994) The immunoglobulin fold. Structural classification, sequence patterns and common core. J Mol Biol 242:309–320
Born WK, Kemal Aydintug M, O’Brien RL (2013) Diversity of gammadelta T-cell antigens. Cell Mol Immunol 10:13–20
Brigl M, Brenner MB (2004) CD1: antigen presentation and T cell function. Annu Rev Immunol 22:817–890
Brocke P, Garbi N, Momburg F, Hammerling GJ (2002) HLA-DM, HLA-DO and tapasin: functional similarities and differences. Curr Opin Immunol 14:22–29
Brown JH, Jardetzky TS, Gorga JC, Stern LJ, Urban RG, Strominger JL, Wiley DC (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33–39
Call ME, Pyrdol J, Wiedmann M, Wucherpfennig KW (2002) The organizing principle in the formation of the T cell receptor-CD3 complex. Cell 111:967–979
Call ME, Wucherpfennig KW (2005) The T cell receptor: critical role of the membrane environment in receptor assembly and function. Annu Rev Immunol 23:101–125
Cardone M, Garcia K, Tilahun ME, Boyd LF, Gebreyohannes S, Yano M, Roderiquez G, Akue AD, Juengst L, Mattson E, Ananthula S, Natarajan K, Puig M, Margulies DH, Norcross MA (2018) A transgenic mouse model for HLA-B*57:01-linked abacavir drug tolerance and reactivity. J Clin Invest 128:2819–2832
Casas J, Brzostek J, Zarnitsyna VI, Hong JS, Wei Q, Hoerter JA, Fu G, Ampudia J, Zamoyska R, Zhu C, Gascoigne NR (2014) Ligand-engaged TCR is triggered by Lck not associated with CD8 coreceptor. Nat Commun 5:5624
Castellino F, Zhong G, Germain RN (1997) Antigen presentation by MHC class II molecules: invariant chain function, protein trafficking, and the molecular basis of diverse determinant capture. Hum Immunol 54:159–169
Clements CS, Kjer-Nielsen L, Kostenko L, Hoare HL, Dunstone MA, Moses E, Freed K, Brooks AG, Rossjohn J, McCluskey J (2005) Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci USA 102:3360–3365
Clements CS, Kjer-Nielsen L, McCluskey J, Rossjohn J (2007) Structural studies on HLA-G: implications for ligand and receptor binding. Hum Immunol 68:220–226
Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, Fanslow W, Kubin M, Chalupny NJ (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14:123–33
Cresswell P, Roche PA (2014) Invariant chain-MHC class II complexes: always odd and never invariant. Immunol Cell Biol 92:471–472
Dai S, Crawford F, Marrack P, Kappler JW (2008) The structure of HLA-DR52c: comparison to other HLA-DRB3 alleles. Proc Natl Acad Sci USA 105:11893–11897
Denzin LK (2013) Inhibition of HLA-DM mediated MHC class II peptide loading by HLA-DO promotes self tolerance. Front Immunol 4:465
Dong G, Wearsch PA, Peaper DR, Cresswell P, Reinisch KM (2009) Insights into MHC class I peptide loading from the structure of the tapasin-ERp57 thiol oxidoreductase heterodimer. Immunity 30:21–32
Dulberger CL, McMurtrey CP, Holzemer A, Neu KE, Liu V, Steinbach AM, Garcia-Beltran WF, Sulak M, Jabri B, Lynch VJ, Altfeld M, Hildebrand WH, Adams EJ (2017) Human leukocyte antigen F presents peptides and regulates immunity through interactions with NK cell receptors. Immunity 46(1018–29):e7
Fields BA, Ober B, Malchiodi EL, Lebedeva MI, Braden BC, Ysern X, Kim JK, Shao X, Ward ES, Mariuzza RA (1995) Crystal structure of the V alpha domain of a T cell antigen receptor. Science 270:1821–1824
Gao GF, Tormo J, Gerth UC, Wyer JR, McMichael AJ, Stuart DI, Bell JI, Jones EY, Jakobsen BK (1997) Crystal structure of the complex between human CD8alpha(alpha) and HLA-A2. Nature 387:630–634
Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC (1996) Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384:134–141
Garcia KC, Degano M, Pease LR, Huang M, Peterson PA, Teyton L, Wilson IA (1998) Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 279:1166–1172
Garcia KC, Degano M, Stanfield RL, Brunmark A, Jackson MR, Peterson PA, Teyton L, Wilson IA (1996) An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274:209–19
Garcia-Alles LF, Giacometti G, Versluis C, Maveyraud L, de Paepe D, Guiard J, Tranier S, Gilleron M, Prandi J, Hanau D, Heck AJ, Mori L, De Libero G, Puzo G, Mourey L, de la Salle H (2011) Crystal structure of human CD1e reveals a groove suited for lipid-exchange processes. Proc Natl Acad Sci USA 108:13230–13235
Garcia-Beltran WF, Holzemer A, Martrus G, Chung AW, Pacheco Y, Simoneau CR, Rucevic M, Lamothe-Molina PA, Pertel T, Kim TE, Dugan H, Alter G, Dechanet-Merville J, Jost S, Carrington M, Altfeld M (2016) Open conformers of HLA-F are high-affinity ligands of the activating NK-cell receptor KIR3DS1. Nat Immunol 17:1067–1074
Garrett TP, Saper MA, Bjorkman PJ, Strominger JL, Wiley DC (1989) Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature 342:692–696
Germain RN, Margulies DH (1993) The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 11:403–450
Gherardin NA, McCluskey J, Rossjohn J, Godfrey DI (2018) The diverse family of MR1-restricted T cells. J Immunol 201:2862–2871
Girardi E, Zajonc DM (2012) Molecular basis of lipid antigen presentation by CD1d and recognition by natural killer T cells. Immunol Rev 250:167–179
Godfrey DI, Pellicci DG, Patel O, Kjer-Nielsen L, McCluskey J, Rossjohn J (2010) Antigen recognition by CD1d-restricted NKT T cell receptors. Semin Immunol 22:61–67
Gold MC, Lewinsohn DM (2013) Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol 11:14–19
Goodridge JP, Lee N, Burian A, Pyo CW, Tykodi SS, Warren EH, Yee C, Riddell SR, Geraghty DE (2013) HLA-F and MHC-I open conformers cooperate in a MHC-I antigen cross-presentation pathway. J Immunol 191:1567–1577
Guce AI, Mortimer SE, Yoon T, Painter CA, Jiang W, Mellins ED, Stern LJ (2012) HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism. Nat Struct Mol Biol
Halenius A, Gerke C, Hengel H (2015) Classical and non-classical MHC I molecule manipulation by human cytomegalovirus: so many targets-but how many arrows in the quiver? Cell Mol Immunol 12:139–153
Harriff MJ, Wolfe LM, Swarbrick G, Null M, Cansler ME, Canfield ET, Vogt T, Toren KG, Li W, Jackson M, Lewinsohn DA, Dobos KM, Lewinsohn DM (2017) HLA-E presents glycopeptides from the mycobacterium tuberculosis protein MPT32 to human CD8(+) T cells. Sci Rep 7:4622
Harvey IB, Wang X, Fremont DH (2019) Molluscum contagiosum virus MC80 sabotages MHC-I antigen presentation by targeting tapasin for ER-associated degradation. PLoS Pathog 15:e1007711
He X, Tabaczewski P, Ho J, Stroynowski I, Garcia KC (2001) Promiscuous antigen presentation by the nonclassical MHC Ib Qa-2 is enabled by a shallow, hydrophobic groove and self-stabilized peptide conformation. Structure 9:1213–1224
He Y, Rangarajan S, Kerzic M, Luo M, Chen Y, Wang Q, Yin Y, Workman CJ, Vignali KM, Vignali DA, Mariuzza RA, Orban J (2015) Identification of the docking site for CD3 on the T cell receptor beta chain by solution NMR. J Biol Chem 290:19796–19805
Hermann C, Strittmatter LM, Deane JE, Boyle LH (2013) The binding of TAPBPR and Tapasin to MHC class I is mutually exclusive. J Immunol 191:5743–5750
Hoare HL, Sullivan LC, Clements CS, Ely LK, Beddoe T, Henderson KN, Lin J, Reid HH, Brooks AG, Rossjohn J (2008) Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. J Mol Biol 377:1297–1303
Huang L, Marvin JM, Tatsis N, Eisenlohr LC (2011) Cutting edge: selective role of ubiquitin in MHC class I antigen presentation. J Immunol 186:1904–1908
Illing PT, Mifsud NA, Purcell AW (2016) Allotype specific interactions of drugs and HLA molecules in hypersensitivity reactions. Curr Opin Immunol 42:31–40
Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, Burrows SR, Purcell AW, Rossjohn J, McCluskey J (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486:554–558
Jensen PE, Weber DA, Thayer WP, Chen X, Dao CT (1999) HLA-DM and the MHC class II antigen presentation pathway. Immunol Res 20:195–205
Jiang J, Natarajan K, Boyd LF, Morozov GI, Mage MG, Margulies DH (2017) Crystal structure of a TAPBPR-MHC I complex reveals the mechanism of peptide editing in antigen presentation. Science 358:1064–1068
Jiang X, Lian M, Li Y, Zhang W, Wang Q, Wei Y, Zhang J, Chen W, Xiao X, Miao Q, Bian Z, Qiu D, Fang J, Ansari AA, Leung PSC, Coppel RL, Tang R, Gershwin ME, Ma X (2018) The immunobiology of mucosal-associated invariant T cell (MAIT) function in primary biliary cholangitis: regulation by cholic acid-induced Interleukin-7. J Autoimmun 90:64–75
Kaiser BK, Pizarro JC, Kerns J, Strong RK (2008) Structural basis for NKG2A/CD94 recognition of HLA-E. Proc Natl Acad Sci USA 105:6696–6701
Karlhofer FM, Ribaudo RK, Yokoyama WM (1992) MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells. Nature 358:66–70
Kim ST, Shin Y, Brazin K, Mallis RJ, Sun ZY, Wagner G, Lang MJ, Reinherz EL (2012) TCR mechanobiology: torques and tunable structures linked to early T cell signaling. Front Immunol 3:76
Kjer-Nielsen L, Patel O, Corbett AJ, Le Nours J, Meehan B, Liu L, Bhati M, Chen Z, Kostenko L, Reantragoon R, Williamson NA, Purcell AW, Dudek NL, McConville MJ, O’Hair RA, Khairallah GN, Godfrey DI, Fairlie DP, Rossjohn J, McCluskey J (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491:717–723
Koch J, Tampe R (2006) The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation. Cell Mol Life Sci 63:653–662
Krissinel E, Henrick K (2007) Inference of macromolecular assemblies from crystalline state. J Mol Biol 372:774–797
Kropshofer H, Vogt AB, Thery C, Armandola EA, Li BC, Moldenhauer G, Amigorena S, Hammerling GJ (1998) A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules. EMBO J 17:2971–2981
Kwong PD, Ryu SE, Hendrickson WA, Axel R, Sweet RM, Folena-Wasserman G, Hensley P, Sweet RW (1990) Molecular characteristics of recombinant human CD4 as deduced from polymorphic crystals. Proc Natl Acad Sci USA 87:6423–6427
Landsverk OJ, Barois N, Gregers TF, Bakke O (2011) Invariant chain increases the half-life of MHC II by delaying endosomal maturation. Immunol Cell Biol 89:619–629
Leahy DJ, Axel R, Hendrickson WA (1992) Crystal structure of a soluble form of the human T cell coreceptor CD8 at 2.6 A resolution. Cell 68:1145–1162
Lee N, Geraghty DE (2003) HLA-F surface expression on B cell and monocyte cell lines is partially independent from tapasin and completely independent from TAP. J Immunol 171:5264–5271
Leem J, de Oliveira SHP, Krawczyk K, Deane CM (2018) STCRDab: the structural T-cell receptor database. Nucleic Acids Res 46:D406–D412
LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED (2003) Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62:273–284
Li P, Morris DL, Willcox BE, Steinle A, Spies T, Strong RK (2001) Complex structure of the activating immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nat Immunol 2:443–451
Ljunggren HG, Stam NJ, Ohlen C, Neefjes JJ, Hoglund P, Heemels MT, Bastin J, Schumacher TN, Townsend A, Karre K et al (1990) Empty MHC class I molecules come out in the cold. Nature 346:476–480
Mallevaey T, Clarke AJ, Scott-Browne JP, Young MH, Roisman LC, Pellicci DG, Patel O, Vivian JP, Matsuda JL, McCluskey J, Godfrey DI, Marrack P, Rossjohn J, Gapin L (2011) A molecular basis for NKT cell recognition of CD1d-self-antigen. Immunity 34:315–326
Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO (1995) Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016–1018
Mans J, Natarajan K, Balbo A, Schuck P, Eikel D, Hess S, Robinson H, Simic H, Jonjic S, Tiemessen CT, Margulies DH (2007) Cellular expression and crystal structure of the murine cytomegalovirus major histocompatibility complex class I-like glycoprotein, m153. J Biol Chem 282:35247–35258
Mans J, Zhi L, Revilleza MJ, Smith L, Redwood A, Natarajan K, Margulies DH (2009) Structure and function of murine cytomegalovirus MHC-I-like molecules: how the virus turned the host defense to its advantage. Immunol Res 43:264–279
Margulies DH, Natarajan K, Rossjohn J, McCluskey J (2013) The major histocompatibility complex (MHC) and its proteins. In: Paul WE (eds) Fundamental immunology. Wolters Kluwer/Lippincott Williams & Wilkins, Philadelphia, pp 487–523
Marks MS, Roche PA, van Donselaar E, Woodruff L, Peters PJ, Bonifacino JS (1995) A lysosomal targeting signal in the cytoplasmic tail of the beta chain directs HLA-DM to MHC class II compartments. J Cell Biol 131:351–369
Marsh SGE (2019) Nomenclature for factors of the HLA system, update October, November, and December 2018. Int J Immunogenet
Marsh SGE, System WHONCfFotH (2018) Nomenclature for factors of the HLA system, update September 2018. HLA 92:354–371
McMichael AJ, Pilch JR, Galfre G, Mason DY, Fabre JW, Milstein C (1979) A human thymocyte antigen defined by a hybrid myeloma monoclonal antibody. Eur J Immunol 9:205–210
McShan AC, Natarajan K, Kumirov VK, Flores-Solis D, Jiang J, Badstubner M, Toor JS, Bagshaw CR, Kovrigin EL, Margulies DH, Sgourakis NG (2018) Peptide exchange on MHC-I by TAPBPR is driven by a negative allostery release cycle. Nat Chem Biol 14:811–820
Mellins ED, Stern LJ (2014) HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation. Curr Opin Immunol 26:115–122
Merry AH, Gilbert RJ, Shore DA, Royle L, Miroshnychenko O, Vuong M, Wormald MR, Harvey DJ, Dwek RA, Classon BJ, Rudd PM, Davis SJ (2003) O-glycan sialylation and the structure of the stalk-like region of the T cell co-receptor CD8. J Biol Chem 278:27119–27128
Miles JJ, Elhassen D, Borg NA, Silins SL, Tynan FE, Burrows JM, Purcell AW, Kjer-Nielsen L, Rossjohn J, Burrows SR, McCluskey J (2005) CTL recognition of a bulged viral peptide involves biased TCR selection. J Immunol 175:3826–3834
Moody DB, Zajonc DM, Wilson IA (2005) Anatomy of CD1-lipid antigen complexes. Nat Rev Immunol 5:387–399
Morozov GI, Zhao H, Mage MG, Boyd LF, Jiang J, Dolan MA, Venna R, Norcross MA, McMurtrey CP, Hildebrand W, Schuck P, Natarajan K, Margulies DH (2016) Interaction of TAPBPR, a tapasin homolog, with MHC-I molecules promotes peptide editing. Proc Natl Acad Sci USA 113:E1006–E1015
Mosyak L, Zaller DM, Wiley DC (1998) The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation. Immunity 9:377–383
Natarajan A, Nadarajah V, Felsovalyi K, Wang W, Jeyachandran VR, Wasson RA, Cardozo T, Bracken C, Krogsgaard M (2016) Structural model of the extracellular assembly of the TCR-CD3 complex. Cell Rep 14:2833–2845
Natarajan K, Boyd L, Schuck P, Yokoyama W, Eilat D, Margulies D (1999) Interaction of the NK cell inhibitory receptor Ly49A with H-2D(d): Identification of a site distinct from the TCR site. Immunity 11:591–601
Natarajan K, Dimasi N, Wang J, Mariuzza R, Margulies D (2002) Structure and function of natural killer cell receptors: multiple molecular solutions to self, nonself discrimination. Annu Rev Immunol 20:853–885
Natarajan K, Hicks A, Mans J, Robinson H, Guan R, Mariuzza RA, Margulies DH (2006) Crystal structure of the murine cytomegalovirus MHC-I homolog m144. J Mol Biol 358:157–171
Natarajan K, Jiang J, May NA, Mage MG, Boyd LF, McShan AC, Sgourakis NG, Bax A, Margulies DH (2018) The role of molecular flexibility in antigen presentation and T cell receptor-mediated signaling. Front Immunol 9:1657
Natarajan K, Mage MG, Margulies DH (2015) Immunoglobulin superfamily. eLS [Online]
Natarajan K, McShan AC, Jiang J, Kumirov VK, Wang R, Zhao H, Schuck P, Tilahun ME, Boyd LF, Ying J, Bax A, Margulies DH, Sgourakis NG (2017) An allosteric site in the T-cell receptor Cbeta domain plays a critical signalling role. Nat Commun 8:15260
Norcross MA, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies DH, McMurtrey C, Vernon S, Hildebrand WH, Buchli R (2012) Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS 26:F21–F29
O’Callaghan CA, Bell JI (1998) Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol Rev 163:129–138
Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, Yang L, Mei H, Shi L, Shabanowitz J, English AM, Wriston A, Lucas A, Phillips E, Mallal S, Grey HM, Sette A, Hunt DF, Buus S, Peters B (2012) Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA 109:9959–9964
Panter MS, Jain A, Leonhardt RM, Ha T, Cresswell P (2012) Dynamics of major histocompatibility complex class I association with the human peptide-loading complex. J Biol Chem 287:31172–31184
Pavlos R, Mallal S, Ostrov D, Buus S, Metushi I, Peters B, Phillips E (2015) T cell-mediated hypersensitivity reactions to drugs. Annu Rev Med 66:439–454
Pavlos R, McKinnon EJ, Ostrov DA, Peters B, Buus S, Koelle D, Chopra A, Schutte R, Rive C, Redwood A, Restrepo S, Bracey A, Kaever T, Myers P, Speers E, Malaker SA, Shabanowitz J, Jing Y, Gaudieri S, Hunt DF, Carrington M, Haas DW, Mallal S, Phillips EJ (2017) Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles. Sci Rep 7:8653
Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, Heroux A, Hoare HL, Beddoe T, Reid HH, Wilce MC, Brooks AG, Rossjohn J (2008) CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence. J Exp Med 205:725–735
Pierce BG, Weng Z (2013) A flexible docking approach for prediction of T cell receptor-peptide-MHC complexes. Protein Sci 22:35–46
Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S (2013) HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation. PLoS ONE 8:e71228
Poluektov YO, Kim A, Sadegh-Nasseri S (2013) HLA-DO and its role in MHC Class II antigen presentation. Front Immunol 4:260
Pos W, Sethi DK, Call MJ, Schulze MS, Anders AK, Pyrdol J, Wucherpfennig KW (2012) Crystal structure of the HLA-DM-HLA-DR1 complex defines mechanisms for rapid peptide selection. Cell 151:1557–1568
Radaev S, Rostro B, Brooks AG, Colonna M, Sun PD (2001) Conformational plasticity revealed by the cocrystal structure of NKG2D and its class I MHC-like ligand ULBP3. Immunity 15:1039–1049
Radaev S, Sun PD (2003) Structure and function of natural killer cell surface receptors. Annu Rev Biophys Biomol Struct 32:93–114
Redwood AJ, Pavlos RK, White KD, Phillips EJ (2018) HLAs: key regulators of T-cell-mediated drug hypersensitivity. HLA 91:3–16
Reiser JB, Legoux F, Gras S, Trudel E, Chouquet A, Leger A, Le Gorrec M, Machillot P, Bonneville M, Saulquin X, Housset D (2014) Analysis of relationships between peptide/MHC structural features and naive T cell frequency in humans. J Immunol 193:5816–5826
Revilleza MJ, Wang R, Mans J, Hong M, Natarajan K, Margulies DH (2011) How the virus outsmarts the host: function and structure of cytomegalovirus MHC-I-like molecules in the evasion of natural killer cell surveillance. J Biomed Biotechnol 2011:724607
Riberdy JM, Newcomb JR, Surman MJ, Barbosa JA, Cresswell P (1992) HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides. Nature 360:474–477
Robinson J, Soormally AR, Hayhurst JD, Marsh SGE (2016) The IPD-IMGT/HLA database—new developments in reporting HLA variation. Hum Immunol 77:233–237
Roche PA, Marks MS, Cresswell P (1991) Formation of a nine-subunit complex by HLA class-II glycoproteins and the invariant chain. Nature 354:392–394
Rock KL, Reits E, Neefjes J (2016) Present yourself! By MHC class I and MHC class II molecules. Trends Immunol 37:724–737
Rossjohn J, Gras S, Miles JJ, Turner SJ, Godfrey DI, McCluskey J (2015) T cell antigen receptor recognition of antigen-presenting molecules. Annu Rev Immunol 33:169–200
Sadegh-Nasseri S, Chou CL, Hartman IZ, Kim A, Narayan K (2012) How HLA-DM works: recognition of MHC II conformational heterogeneity. Front Biosci (Schol Ed) 4:1325–1332
Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219:277–319
Scharf L, Li NS, Hawk AJ, Garzon D, Zhang T, Fox LM, Kazen AR, Shah S, Haddadian EJ, Gumperz JE, Saghatelian A, Faraldo-Gomez JD, Meredith SC, Piccirilli JA, Adams EJ (2010) The 2.5 A structure of CD1c in complex with a mycobacterial lipid reveals an open groove ideally suited for diverse antigen presentation. Immunity 33:853–862
Scholz C, Tampe R (2005) The intracellular antigen transport machinery TAP in adaptive immunity and virus escape mechanisms. J Bioenerg Biomembr 37:509–515
Sette A, Ceman S, Kubo RT, Sakaguchi K, Appella E, Hunt DF, Davis TA, Michel H, Shabanowitz J, Rudersdorf R et al (1992) Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. Science 258:1801–1804
Sette A, DeMars R, Grey HM, Oseroff C, Southwood S, Appella E, Kubo RT, Hunt DF (1993) Isolation and characterization of naturally processed peptides bound by class II molecules and peptides presented by normal and mutant antigen-presenting cells. Chem Immunol 57:152–165
Shaler CR, Choi J, Rudak PT, Memarnejadian A, Szabo PA, Tun-Abraham ME, Rossjohn J, Corbett AJ, McCluskey J, McCormick JK, Lantz O, Hernandez-Alejandro R, Haeryfar SMM (2017) MAIT cells launch a rapid, robust and distinct hyper-inflammatory response to bacterial superantigens and quickly acquire an anergic phenotype that impedes their cognate antimicrobial function: defining a novel mechanism of superantigen-induced immunopathology and immunosuppression. PLoS Biol 15:e2001930
Shiroishi M, Kuroki K, Ose T, Rasubala L, Shiratori I, Arase H, Tsumoto K, Kumagai I, Kohda D, Maenaka K (2006) Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer. J Biol Chem 281:10439–10447
Sim MJW, Sun PD (2017) HLA-F: a new kid licensed for peptide presentation. Immunity 46:972–974
Stern LJ, Brown JH, Jardetzky TS, Gorga JC, Urban RG, Strominger JL, Wiley DC (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215–221
Strong RK, Holmes MA, Li P, Braun L, Lee N, Geraghty DE (2003) HLA-E allelic variants. Correlating differential expression, peptide affinities, crystal structures, and thermal stabilities. J Biol Chem 278:5082–5090
Sullivan LC, Clements CS, Rossjohn J, Brooks AG (2008) The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity. Tissue Antigens 72:415–424
Sutherland CL, Chalupny NJ, Cosman D (2001) The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. Immunol Rev 181:185–192
Thomas C, Tampe R (2019) MHC I chaperone complexes shaping immunity. Curr Opin Immunol 58:9–15
Tormo J, Natarajan K, Margulies D, Marluzza R (1999) Crystal structure of a lectin-like natural killer cell receptor bound to its MHC class I ligand. Nature 402:623–631
Tynan FE, Burrows SR, Buckle AM, Clements CS, Borg NA, Miles JJ, Beddoe T, Whisstock JC, Wilce MC, Silins SL, Burrows JM, Kjer-Nielsen L, Kostenko L, Purcell AW, McCluskey J, Rossjohn J (2005) T cell receptor recognition of a ‘super-bulged’ major histocompatibility complex class I-bound peptide. Nat Immunol 6:1114–1122
van Hateren A, Carter R, Bailey A, Kontouli N, Williams AP, Kaufman J, Elliott T (2013) A mechanistic basis for the co-evolution of chicken tapasin and major histocompatibility complex class I (MHC I) proteins. J Biol Chem 288:32797–32808
Van Hateren A, James E, Bailey A, Phillips A, Dalchau N, Elliott T (2010) The cell biology of major histocompatibility complex class I assembly: towards a molecular understanding. Tissue Antigens 76:259–275
Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, Wheeler DK, Sette A, Peters B (2019) The immune epitope database (IEDB): 2018 update. Nucleic Acids Res 47:D339–D343
Wainwright SD, Biro PA, Holmes CH (2000) HLA-F is a predominantly empty, intracellular, TAP-associated MHC class Ib protein with a restricted expression pattern. J Immunol 164:319–328
Walpole NG, Kjer-Nielsen L, Kostenko L, McCluskey J, Brooks AG, Rossjohn J, Clements CS (2010) The structure and stability of the monomorphic HLA-G are influenced by the nature of the bound peptide. J Mol Biol 397:467–480
Wang CR, Castano AR, Peterson PA, Slaughter C, Lindahl KF, Deisenhofer J (1995) Nonclassical binding of formylated peptide in crystal structure of the MHC class Ib molecule H2-M3. Cell 82:655–664
Wang J, Whitman M, Natarajan K, Tormo J, Mariuzza R, Margulies D (2002) Binding of the natural killer cell inhibitory receptor Ly49A to its major histocompatibility complex class I ligand—crucial contacts include both H-2D(d) and beta(2)-microglobulin. J Biol Chem 277:1433–1442
Wang JH, Yan YW, Garrett TP, Liu JH, Rodgers DW, Garlick RL, Tarr GE, Husain Y, Reinherz EL, Harrison SC (1990) Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature 348:411–418
Wang R, Natarajan K, Margulies DH (2009) Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position. J Immunol 183:2554–2564
Wang R, Natarajan K, Revilleza MJ, Boyd LF, Zhi L, Zhao H, Robinson H, Margulies DH (2012) Structural basis of mouse cytomegalovirus m152/gp40 interaction with RAE1gamma reveals a paradigm for MHC/MHC interaction in immune evasion. Proc Natl Acad Sci USA 109:E3578–E3587
Wang XX, Li Y, Yin Y, Mo M, Wang Q, Gao W, Wang L, Mariuzza RA (2011) Affinity maturation of human CD4 by yeast surface display and crystal structure of a CD4-HLA-DR1 complex. Proc Natl Acad Sci USA 108:15960–15965
Watanabe H, Watanabe Y, Tashiro Y, Mushiroda T, Ozeki T, Hashizume H, Sueki H, Yamamoto T, Utsunomiya-Tate N, Gouda H, Kusakabe Y (2017) A docking model of dapsone bound to HLA-B*13:01 explains the risk of dapsone hypersensitivity syndrome. J Dermatol Sci 88:320–329
Wei J, Yewdell JW (2018) Immunoribosomes: where’s there’s fire, there’s fire. Mol Immunol
Wolan DW, Teyton L, Rudolph MG, Villmow B, Bauer S, Busch DH, Wilson IA (2001) Crystal structure of the murine NK cell-activating receptor NKG2D at 1.95 A. Nat Immunol 2:248–254
Wun KS, Cameron G, Patel O, Pang SS, Pellicci DG, Sullivan LC, Keshipeddy S, Young MH, Uldrich AP, Thakur MS, Richardson SK, Howell AR, Illarionov PA, Brooks AG, Besra GS, McCluskey J, Gapin L, Porcelli SA, Godfrey DI, Rossjohn J (2011) A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells. Immunity 34:327–339
Yang Z, Bjorkman PJ (2008) Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Proc Natl Acad Sci USA 105:10095–10100
Yin Y, Wang XX, Mariuzza RA (2012) Crystal structure of a complete ternary complex of T-cell receptor, peptide-MHC, and CD4. Proc Natl Acad Sci USA 109:5405–5410
York IA, Rock KL (1996) Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14:369–396
Zajonc DM (2016) The CD1 family: serving lipid antigens to T cells since the Mesozoic era. Immunogenetics 68:561–576
Zajonc DM, Elsliger MA, Teyton L, Wilson IA (2003) Crystal structure of CD1a in complex with a sulfatide self antigen at a resolution of 2.15 A. Nat Immunol 4:808–815
Zajonc DM, Flajnik MF (2016) CD1, MR1, NKT, and MAIT: evolution and origins of non-peptidic antigen recognition by T lymphocytes. Immunogenetics 68:489–490
Zarutskie JA, Busch R, Zavala-Ruiz Z, Rushe M, Mellins ED, Stern LJ (2001) The kinetic basis of peptide exchange catalysis by HLA-DM. Proc Natl Acad Sci USA 98:12450–12455
Zeng L, Sullivan LC, Vivian JP, Walpole NG, Harpur CM, Rossjohn J, Clements CS, Brooks AG (2012) A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b. J Immunol 188:302–310
Zeng Z, Castano AR, Segelke BW, Stura EA, Peterson PA, Wilson IA (1997) Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove. Science 277:339–345
Acknowledgements
We appreciate the continued support both intellectual and scientific of the members of our laboratory. This work was supported by the intramural research program of the NIAID, NIH. We apologize for any deficiencies in the citation of original studies.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Jiang, J., Natarajan, K., Margulies, D.H. (2019). MHC Molecules, T cell Receptors, Natural Killer Cell Receptors, and Viral Immunoevasins—Key Elements of Adaptive and Innate Immunity. In: Jin, T., Yin, Q. (eds) Structural Immunology. Advances in Experimental Medicine and Biology, vol 1172. Springer, Singapore. https://doi.org/10.1007/978-981-13-9367-9_2
Download citation
DOI: https://doi.org/10.1007/978-981-13-9367-9_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-9366-2
Online ISBN: 978-981-13-9367-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)